Adem Alemdar
Overview
Explore the profile of Adem Alemdar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuce B, Kalay O, Karpat F, Alemdar A, Temel S, Dilektasli A, et al.
J Environ Health Sci Eng
. 2024 Oct;
22(2):471-482.
PMID: 39464828
The novel coronavirus (SARS-CoV-2) outbreak has spread worldwide, and the World Health Organization (WHO) declared a global pandemic in March 2020. The transmission mechanism of SARS-CoV-2 in indoor environments has...
2.
Kole I, Vural P, Yurdacan B, Alemdar A, Mutlu C
Eur J Clin Pharmacol
. 2024 Aug;
80(11):1773-1785.
PMID: 39158690
Background: There is insufficient replicated data to establish a relationship between the polymorphisms of SLC6A2 and CYP2D6 and the treatment responses of atomoxetine (ATX) in ADHD. We focused on evaluating...
3.
Aliyeva L, Ongen Y, Eren E, Sarisozen M, Alemdar A, Temel S, et al.
J Mol Diagn
. 2024 Jul;
26(9):754-769.
PMID: 39025364
Osteogenesis imperfecta (OI) is the most common inherited connective tissue disease of the bone, characterized by recurrent fractures and deformities. In patients displaying the OI phenotype, genotype-phenotype correlation is used...
4.
Ismail A, Dundar M, Erguzeloglu C, Ergoren M, Alemdar A, Sag S, et al.
Biomedicines
. 2024 May;
12(5).
PMID: 38790930
Alzheimer's disease (AD) is a major global health challenge, especially among individuals aged 65 or older. According to population health studies, Turkey has the highest AD prevalence in the Middle...
5.
Boga I, Sag S, Duman N, Ozdemir S, Ergoren M, Dalci K, et al.
Eur J Breast Health
. 2023 Jul;
19(3):235-252.
PMID: 37415649
Objective: Breast cancer (BC) is the most common cancer type in women and may be inherited, mostly in an autosomal dominant pattern. The clinical diagnosis of BC relies on the...
6.
Kiraz A, Sezer O, Alemdar A, Canbek S, Duman N, Bisgin A, et al.
J Med Virol
. 2023 Jan;
95(2):e28457.
PMID: 36597901
Thrombotic and microangiopathic effects have been reported in COVID-19 patients. This study examined the contribution of the hereditary thrombophilia factors Prothrombin (FII) and Factor V Leiden (FVL) genotypes to the...
7.
Duman N, Tuncel G, Bisgin A, Bozdogan S, Sag S, Gul S, et al.
J Med Virol
. 2022 Jul;
94(11):5225-5243.
PMID: 35811452
Heterogeneity in symptoms associated with COVID-19 in infected patients remains unclear. ACE2 and TMPRSS2 gene variants are considered possible risk factors for COVID-19. In this study, a retrospective comparative genome...
8.
Bisgin A, Sag S, Dogan M, Yildirim M, Gumus A, Akkus N, et al.
Breast
. 2022 Jun;
65:15-22.
PMID: 35753294
BRCA1/2 mutations play a significant role in cancer pathogenesis and predisposition particularly in breast, ovarian and prostate cancers. Thus, germline analysis of BRCA1 and BRCA2 is essential for clinical management...
9.
Dundar M, Fahrioglu U, Yildiz S, Bakir-Gungor B, Temel S, Akin H, et al.
Funct Integr Genomics
. 2022 Jan;
22(3):291-315.
PMID: 35098403
Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disorder with recurrent fever, abdominal pain, serositis, articular manifestations, erysipelas-like erythema, and renal complications as its main features. Caused by the mutations...
10.
Deligonul A, Aksoy S, Tezcan G, Tunca B, Kanat O, Cubukcu E, et al.
Genet Test Mol Biomarkers
. 2021 Apr;
25(4):276-283.
PMID: 33877893
In 10-30% of colorectal cancer (CRC) patients, toxic reactions occur after fluoropyrimidine-based chemotherapy. A dihydropyridine dehydrogenase ( gene variant, c.1905 + 1G>A, leads to intolerance to fluoropyrimidines. Due to the...